XNAS · Healthcare · Diagnostics & Research
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 | Q2 2026 | -0.53 | -0.59 | -11.32% | $110.7M | ❌ Miss | +4.57% | +0.04% | +28.72% |
| 2026-02-02 | Q1 2026 | -0.50 | -0.50 | +0.00% | $103.7M | ➖ Inline | -1.66% | +1.41% | +2.67% |
| 2025-11-14 |
| Q4 2025 |
| -0.46 |
| -0.45 |
| +2.17% |
| $99.0M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-04 | Q3 2025 | -0.56 | -0.47 | +16.07% | $96.1M | ✅ Beat | -3.44% | -8.54% | -13.94% |
| 2025-02-03 | Q1 2025 | -0.63 | -0.53 | +15.87% | $88.7M | ✅ Beat | -1.38% | -7.81% | -20.28% |
| 2024-11-18 | Q4 2024 | -0.69 | -0.59 | +14.49% | $84.7M | ✅ Beat | -0.27% | +12.00% | +7.68% |
| 2024-08-02 | Q3 2024 | -0.77 | -0.70 | +9.09% | $81.5M | ✅ Beat | +5.49% | +2.33% | -4.68% |
| 2024-05-02 | Q2 2024 | -0.81 | -0.79 | +2.47% | $75.3M | ✅ Beat | +28.74% | +34.96% | +37.49% |
Showing last 8 quarters.